Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?

Detalhes bibliográficos
Autor(a) principal: Pinho, André
Data de Publicação: 2017
Outros Autores: Santiago, Luís, Gonçalo, Margarida
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.29021/spdv.75.2.770
Resumo: Introduction: Like in allergic contact dermatitis, in non-immediate (NI) cutaneous adverse drug reactions (CADR) delayed hypersensitivity to antibiotics and anticonvulsants is considered to be lifelong. Although in allergic contact dermatitis patch tests remain positive for several years, this has seldom been assessed in the setting of NI-CADR to systemic drugs.Objective: To evaluate the long term behaviour of positive patch test reactions in NI-CADR to beta-lactams, clindamycin and carbamazepine. Methods: The drugs associated with the largest number of positive patch test reactions (beta-lactams, clindamycin and carbamazepin) were selected and 64 patients with history of NI-CADR to these drugs and relevant positive reactions were invited to repeat patch tests, at least 2 years thereafter. New patch test reactions were compared with the original ones.Results: In the 23 patients included in the study (10 males/ 13 females, median age 51 years) there were 44 positive reactions at the first patch tests and 40 (91.1%) of these remained positive after a median interval of 6.5 years (min. 2.0 – max. 30.7 years). Concerning beta-lactams, 17/19 reactions persisted positive for aminopenicillins (amoxicillin or ampicillin), 8/8 for isoxazolyl penicillins (flucloxacillin or dicloxacillin), 3/3 for benzylpenicillin, 1/1 for cefoxitin and 1/1 with piperacillin. Reactions with clindamycin remained positive in 5/7 cases. All five patch tests repeated with carbamazepine were positive. In 62.5% of the tests the same intensity of reaction was observed and was not affected by the time interval between tests, gender or age at performing patch tests.Conclusion: In NI-CADR to several antibiotics and carbamazepine, most of the patch test reactions remained positive after several years.
id RCAP_30f3ff18158aa6c756e7e17e6d37520f
oai_identifier_str oai:ojs.revista.spdv.com.pt:article/770
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?Reações Cutâneas de Hipersensibilidade Retardada a Medicamentos: Serão os Testes Epicutâneos Positivos Persistentes?beta-LactamsCarbamazepineClindamycinDrug EruptionsDrug HypersensitivityHypersensitivityDelayed/ chemically inducedPatch Testsbeta-LactâmicosCarbamazepinaClindamicinaErupção por MedicamentosHipersensibilidade a MedicamentosHipersensibilidade Retardada/induzida quimicamenteTestes EpicutâneosIntroduction: Like in allergic contact dermatitis, in non-immediate (NI) cutaneous adverse drug reactions (CADR) delayed hypersensitivity to antibiotics and anticonvulsants is considered to be lifelong. Although in allergic contact dermatitis patch tests remain positive for several years, this has seldom been assessed in the setting of NI-CADR to systemic drugs.Objective: To evaluate the long term behaviour of positive patch test reactions in NI-CADR to beta-lactams, clindamycin and carbamazepine. Methods: The drugs associated with the largest number of positive patch test reactions (beta-lactams, clindamycin and carbamazepin) were selected and 64 patients with history of NI-CADR to these drugs and relevant positive reactions were invited to repeat patch tests, at least 2 years thereafter. New patch test reactions were compared with the original ones.Results: In the 23 patients included in the study (10 males/ 13 females, median age 51 years) there were 44 positive reactions at the first patch tests and 40 (91.1%) of these remained positive after a median interval of 6.5 years (min. 2.0 – max. 30.7 years). Concerning beta-lactams, 17/19 reactions persisted positive for aminopenicillins (amoxicillin or ampicillin), 8/8 for isoxazolyl penicillins (flucloxacillin or dicloxacillin), 3/3 for benzylpenicillin, 1/1 for cefoxitin and 1/1 with piperacillin. Reactions with clindamycin remained positive in 5/7 cases. All five patch tests repeated with carbamazepine were positive. In 62.5% of the tests the same intensity of reaction was observed and was not affected by the time interval between tests, gender or age at performing patch tests.Conclusion: In NI-CADR to several antibiotics and carbamazepine, most of the patch test reactions remained positive after several years.Introdução: Tal como na dermatite de contacto alérgica, nas reações adversas medicamentosas cutâneas (RAMc) retardadas a hipersensibilidade é considerada permanente. No entanto, enquanto na dermatite de contacto alérgica os testes epicutâneos permanecem positivos por longos períodos de tempo, isto tem sido pouco estudado nas RAMc retardadas medicamentos sistémicos.Objetivo: Avaliar, a longo prazo, a persistência das reações positivas dos testes epicutâneos nas RAMc retardadas a antibióticos betalactâmicos, à clindamicina e à carbamazepina. Métodos: Foram selecionados os medicamentos com maior número de reações positivas em testes epicutâneos (betalactâmicos, clindamicina e carbamazepina) e 64 doentes com história de RAMc retardadas com testes positivos a estes fármacos foram convidados a repetir os testes, pelo menos 2 anos depois dos primeiros. As reações dos novos testes foram comparadas com as dos testes originais.Resultados: Nos 23 doentes que aceitaram participar (10 homens/13 mulheres, idade mediana 51 anos) foram observadas 44 reações positivas nos testes iniciais e 40 (91,1%) destas mantiveram-se positivas, após uma mediana de 6,5 anos (min. 2,0 – máx. 30,7 anos). Relativamente aos betalactâmicos, 17/19 reações permaneceram positivas com aminopenicilinas (amoxicilina ou ampicilina), 8/8 com isoxazolilpenicilinas (flucloxacilina ou dicloxacilina), 3/3 com benzilpenicilina, 1/1 cefoxitina e 1/1 com piperacilina. Os testes com clindamicina mantiveram-se positivos em 5/7 ocasiões. Todos os cinco testes repetidos com carbamazepina foram positivos. Em 62,5% das reações observou-se a mesma intensidade da reação original, não sendo esta afetada pelo tempo decorrido entre os testes, pela idade ou género dos doentes.Conclusão: Nas RAMc retardadas a vários antibióticos e à carbamazepina, a maioria das reações dos testes epicutâneos permaneceu positiva, após vários anos.Sociedade Portuguesa de Dermatologia e Venereologia2017-07-20T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://doi.org/10.29021/spdv.75.2.770oai:ojs.revista.spdv.com.pt:article/770Journal of the Portuguese Society of Dermatology and Venereology; Vol 75 No 2 (2017): Abril - Junho; 155-162Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 75 n. 2 (2017): Abril - Junho; 155-1622182-24092182-2395reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spdv.com.pt/index.php/spdv/article/view/770https://doi.org/10.29021/spdv.75.2.770https://revista.spdv.com.pt/index.php/spdv/article/view/770/494Pinho, AndréSantiago, LuísGonçalo, Margaridainfo:eu-repo/semantics/openAccess2022-10-06T12:35:03Zoai:ojs.revista.spdv.com.pt:article/770Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:11:02.408887Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?
Reações Cutâneas de Hipersensibilidade Retardada a Medicamentos: Serão os Testes Epicutâneos Positivos Persistentes?
title Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?
spellingShingle Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?
Pinho, André
beta-Lactams
Carbamazepine
Clindamycin
Drug Eruptions
Drug Hypersensitivity
Hypersensitivity
Delayed/ chemically induced
Patch Tests
beta-Lactâmicos
Carbamazepina
Clindamicina
Erupção por Medicamentos
Hipersensibilidade a Medicamentos
Hipersensibilidade Retardada/induzida quimicamente
Testes Epicutâneos
title_short Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?
title_full Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?
title_fullStr Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?
title_full_unstemmed Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?
title_sort Non-Immediate Cutaneous Hypersensitivity Drug Reactions: Are Positive Patch Tests Long-Lasting?
author Pinho, André
author_facet Pinho, André
Santiago, Luís
Gonçalo, Margarida
author_role author
author2 Santiago, Luís
Gonçalo, Margarida
author2_role author
author
dc.contributor.author.fl_str_mv Pinho, André
Santiago, Luís
Gonçalo, Margarida
dc.subject.por.fl_str_mv beta-Lactams
Carbamazepine
Clindamycin
Drug Eruptions
Drug Hypersensitivity
Hypersensitivity
Delayed/ chemically induced
Patch Tests
beta-Lactâmicos
Carbamazepina
Clindamicina
Erupção por Medicamentos
Hipersensibilidade a Medicamentos
Hipersensibilidade Retardada/induzida quimicamente
Testes Epicutâneos
topic beta-Lactams
Carbamazepine
Clindamycin
Drug Eruptions
Drug Hypersensitivity
Hypersensitivity
Delayed/ chemically induced
Patch Tests
beta-Lactâmicos
Carbamazepina
Clindamicina
Erupção por Medicamentos
Hipersensibilidade a Medicamentos
Hipersensibilidade Retardada/induzida quimicamente
Testes Epicutâneos
description Introduction: Like in allergic contact dermatitis, in non-immediate (NI) cutaneous adverse drug reactions (CADR) delayed hypersensitivity to antibiotics and anticonvulsants is considered to be lifelong. Although in allergic contact dermatitis patch tests remain positive for several years, this has seldom been assessed in the setting of NI-CADR to systemic drugs.Objective: To evaluate the long term behaviour of positive patch test reactions in NI-CADR to beta-lactams, clindamycin and carbamazepine. Methods: The drugs associated with the largest number of positive patch test reactions (beta-lactams, clindamycin and carbamazepin) were selected and 64 patients with history of NI-CADR to these drugs and relevant positive reactions were invited to repeat patch tests, at least 2 years thereafter. New patch test reactions were compared with the original ones.Results: In the 23 patients included in the study (10 males/ 13 females, median age 51 years) there were 44 positive reactions at the first patch tests and 40 (91.1%) of these remained positive after a median interval of 6.5 years (min. 2.0 – max. 30.7 years). Concerning beta-lactams, 17/19 reactions persisted positive for aminopenicillins (amoxicillin or ampicillin), 8/8 for isoxazolyl penicillins (flucloxacillin or dicloxacillin), 3/3 for benzylpenicillin, 1/1 for cefoxitin and 1/1 with piperacillin. Reactions with clindamycin remained positive in 5/7 cases. All five patch tests repeated with carbamazepine were positive. In 62.5% of the tests the same intensity of reaction was observed and was not affected by the time interval between tests, gender or age at performing patch tests.Conclusion: In NI-CADR to several antibiotics and carbamazepine, most of the patch test reactions remained positive after several years.
publishDate 2017
dc.date.none.fl_str_mv 2017-07-20T00:00:00Z
dc.type.driver.fl_str_mv journal article
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.29021/spdv.75.2.770
oai:ojs.revista.spdv.com.pt:article/770
url https://doi.org/10.29021/spdv.75.2.770
identifier_str_mv oai:ojs.revista.spdv.com.pt:article/770
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revista.spdv.com.pt/index.php/spdv/article/view/770
https://doi.org/10.29021/spdv.75.2.770
https://revista.spdv.com.pt/index.php/spdv/article/view/770/494
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Dermatologia e Venereologia
publisher.none.fl_str_mv Sociedade Portuguesa de Dermatologia e Venereologia
dc.source.none.fl_str_mv Journal of the Portuguese Society of Dermatology and Venereology; Vol 75 No 2 (2017): Abril - Junho; 155-162
Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 75 n. 2 (2017): Abril - Junho; 155-162
2182-2409
2182-2395
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130566665175040